Barthel David

Chief Executive Officer, DirectorMARIZYME INC (MRZM) · full profile →Form 4 · filed Feb 9, 2022
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
0 non-derivative · 2 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Feb 8, 2022Disposed to issuer(D)400K0
Feb 8, 2022Grant(A)400K400K

Transaction Codes

D
Disposition to the issuer
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001493152-22-003650) within minutes of acceptance. Every field above traces to the original document. Verify it directly: